Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas

CONTEXT: Metastatic pheochromocytomas and paragangliomas (mPPGL) are rare vascular neuroendocrine tumors that highly express vascular growth factors. Systemic treatment options in cases of unresectable multisite disease are limited. Multikinase inhibitors that inhibit angiogenesis, such as lenvatini...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan Nelson, Lauren, Fuentes-Bayne, Harry, Yin, Jun, Asmus, Erik, Ryder, Mabel, Morris, John C, Hilger, Crystal R, Bible, Keith C, Chintakuntlawar, Ashish V, Rao, Sarika N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989149/
https://www.ncbi.nlm.nih.gov/pubmed/35402763
http://dx.doi.org/10.1210/jendso/bvac044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989149/
https://www.ncbi.nlm.nih.gov/pubmed/35402763
http://dx.doi.org/10.1210/jendso/bvac044

Ejemplares similares